[46] Similar observations have been reported for hepatocellular cancer, where PDLIM1 silencing promotes epithelial-to-mesenchymal transition and metastasis, whereas PDLIM1 overexpression has the opposite effect [47]. Here, PDLIM1 is linked to hepatocellular carcinoma.